Division of microbiology and infectious diseases (DMID) clinical materials services

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201700085C
Awardee
Awarding agency
Obligated
$24,948,662

Award facts

Opportunity
Contract value 82% obligated
  • $24,948,662.07 Current, with exercised options
  • $30,543,075.07 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 · Deobligate FY21 lines -$52,431
Funding Only Action P00012 · The purpose of this modification is to provide cost overrun funds for the base, option 1, option 2 and option 3. $867,995
Other Administrative Action P00011 · Clinical materials service $0
Exercise an Option P00009 · To exercise term option 4 in the amount of $4,601,795 $4,601,795
Exercise an Option P00010 · Is to issue a option 3 cost overrun $1,012,615
Other Administrative Action P00008 · To change the primary COR from janice arega to michelle wildman. $0
Other Administrative Action P00007 $303,679
Exercise an Option P00006 · To manage and operate a cgmp-compliant clinical materials services facility. $4,465,388
Exercise an Option P00005 · Option period 2. 09/22/2019 - 09/21/2020. $4,353,745
Exercise an Option 4 · Option period 1. 09/22/2018 - 09/21/2019. $4,227,098
Funding Only Action 3 · To revise article B.2., funding a cost overrun of the base period of the contract. $1,068,900
Other Administrative Action 2 · To revise article C.2, reporting requirements, section 1 E., changing the current financial status report due date from the 15TH of the month to the 25TH of the… $0
Other Administrative Action 1 · To revise article G.2. Key personnel, replacing DR. John kudrick with DR. Dennis eyler. $0
Original award $4,099,878
Show all 14

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases awarded a $30.5 million definitive contract to Fisher Bioservices Inc. for Division of Microbiology and Infectious Diseases clinical materials services on September 11, 2017, with ultimate completion July 14, 2023, under a cost-plus-fixed-fee pricing structure and no set-aside.

Place of performance is Rockville, MD. The contract covers biospecimen repository management, storage maintenance, and distribution of biological specimens, cell lines, clinical trial materials, and pharmaceutical compounds supporting DMID operations and clinical trials. Fisher Bioservices operates as the Clinical Trials Division of Thermo Electron Corporation.

Service Contract Inventory reporting shows the contract invoiced $5.7 million in FY2020, $6.4 million in FY2021 with 8.8 FTEs across 18,270 contractor hours at a derived rate of $351.27 per hour, declined to $4.5 million in FY2022 with 8.1 FTEs across 16,793 contractor hours at $266.29 per hour, and $1.1 million in FY2023. Fisher Bioservices self-performed all reported work with no subcontractor engagement on this contract.

Quick answers

Who was awarded contract HHSN272201700085C?

HHSN272201700085C was awarded to Fisher Bioservices Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 11, 2017.

How much is contract HHSN272201700085C worth?

The government has obligated $24,948,662 on HHSN272201700085C. Its potential value, with all options, is $30,543,075.

Was contract HHSN272201700085C competed?

The extent of competition for HHSN272201700085C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login